ASTL ASPARTATE AMINOTRANSFERASE - PYRIDOXAL PHOSPHATE ACTIVATED

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-06-02 for ASTL ASPARTATE AMINOTRANSFERASE - PYRIDOXAL PHOSPHATE ACTIVATED manufactured by Roche Diagnostics.

Event Text Entries

[76519374] (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[76519375] The customer states that a physician complained about fluctuating sample values for 5 samples from the same patient tested for astl aspartate aminotransferase acc. To ifcc without pyridoxal phosphate activation (ast) and altl alanine aminotransferase acc. To ifcc without pyridoxal phosphate activation (alt) on a cobas 6000 c (501) module - c501. All results were reported outside of the laboratory. This medwatch will apply to ast. Please refer to the medwatch with (b)(6) for information related to alt. The physician believed the results to be too different when compared from day to day. No adverse events were alleged to have occurred to the patient. The c501 analyzer serial number was (b)(4).
Patient Sequence No: 1, Text Type: D, B5


[78489340] The issue occurred only with one patient and all other tests run on the patient's samples were not affected. A specific root cause could not be determined based on the available information. Additional information required for the investigation was requested but not provided. Fluctuating interferences in connection with the alt and ast assays are not known. It is possible that an issue with pre-analytic handling occurred. Based upon medical assessment, highly varying ast and alt values can be caused by disease such as sepsis. Day to day variation of aminotransferases with this patient condition can be 10 - 30 %. Controls began to drift down and exhibit imprecision on (b)(6) 2017, but controls were still within range. Based on calibration and control results being within range and precision studies, an issue with the reagent or hardware can be excluded.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-01129
MDR Report Key6607475
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-06-02
Date of Report2017-06-27
Date of Event2017-05-06
Date Mfgr Received2017-05-16
Date Added to Maude2017-06-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameASTL ASPARTATE AMINOTRANSFERASE - PYRIDOXAL PHOSPHATE ACTIVATED
Generic NameNADH OXIDATION/NAD REDUCTION, AST/SGOT
Product CodeCIT
Date Received2017-06-02
Model NumberNA
Catalog NumberASKU
Lot Number195496
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-06-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.